Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). PetVivo Holdings's share price for the quarter that ended in Dec. 2023 was $1.06. PetVivo Holdings's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 14.92 Mil. Therefore, PetVivo Holdings's market cap for the quarter that ended in Dec. 2023 was $15.82 Mil.
PetVivo Holdings's quarterly market cap
increased
from Jun. 2023 ($23.31 Mil) to Sep. 2023 ($25.47 Mil) but then
declined
from Sep. 2023 ($25.47 Mil) to Dec. 2023 ($15.82 Mil).
PetVivo Holdings's annual market cap
declined
from Mar. 2021 ($71.39 Mil) to Mar. 2022 ($20.38 Mil) but then
increased
from Mar. 2022 ($20.38 Mil) to Mar. 2023 ($30.11 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. PetVivo Holdings's Enterprise Value for Today is $15.07 Mil.
PetVivo Holdings Market Cap Historical Data
The historical data trend for PetVivo Holdings's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of PetVivo Holdings's Market Cap
For the Medical Devices subindustry, PetVivo Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PetVivo Holdings's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PetVivo Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where PetVivo Holdings's Market Cap falls into.
PetVivo Holdings Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
PetVivo Holdings's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PetVivo Holdings (OTCPK:PETV) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
PetVivo Holdings Market Cap Related Terms
Thank you for viewing the detailed overview of PetVivo Holdings's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
PetVivo Holdings (PetVivo Holdings) Business Description
PetVivo Holdings Inc is an emerging biomedical device company. The group is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for companion animals. A key strategy of the company is to leverage human therapies for the treatment of companion animals cost-effectively and in a timely manner. The accelerated timeline to revenues for veterinary medical devices is a key component of this strategy, which enter the market much earlier than pharmaceuticals and biologics. The product pipeline includes approximately seventeen products intended to treat animals and people. Its patent protection extends to biomaterials, products, production processes, and methods of use provided by the company's portfolio of nineteen patents.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PETV has been successfully added to your 